Basic Principles and Clinical Relevance of the IAS–USA 2022 Update of the Drug Resistance Mutations in HIV-1
Overview Assessment of Needs This webinar is useful for those who wish to utilize the IAS–USA 2022 Update of the Drug Resistance Mutations in HIV-1 for the management of antiretroviral therapy (ART) in their patients with HIV. This webinar will review the principles of HIV drug resistance mutations and summarize what is currently known about resistance to (more…)
Substance Use Disorder Webinar Series: Bonus Question-and-Answer Session
Overview Assessment of Needs The 6-part IAS–USA webinar series on substance use disorder (SUD), designed by expert faculty Sandra A. Springer, MD, and Ellen F. Eaton, MD, has been a resounding success, with the first 5 webinars now available on-demand and webinar 6 open for registration (see below for more information). Due to the (more…)
No Mo FOMO—In Case You Missed It: Recent Changes in Guidelines, New Publications, and Updates From Recent Conferences
Overview Assessment of Needs The management and treatment of patients with HIV constantly evolves as new data are presented at conferences and published in scholarly journals. This webinar summarizes current and new data on the HIV epidemic, including data from recent clinical trials and updates from recent conferences. Topics include the management of people (more…)
Mpox: Where Are We Now?
Overview Assessment of Needs Mpox illnesses, including severe infections, continue to occur across the United States and around the world. According to the Centers for Disease Control and Prevention, people with HIV-associated immunosuppression and people with HIV who are not virologically suppressed can be at increased risk of severe mpox. This webinar will provide an update on what clinicians need to know regarding (more…)
New Drugs on the Horizon for HIV Treatment: 2024 and Beyond!
Overview Assessment of Needs Innovative medications for the treatment of people with HIV-1 continue to undergo rigorous research and development. This webinar will discuss current data around the latest pharmacologic treatments for HIV, including new data presented at the 31st Conference on Retroviruses and Opportunistic Infections, and new investigational agents in the development pipeline. (more…)
Antiretroviral Management of HIV: New Data From the 2024 Conference on Retroviruses and Opportunistic Infections (CROI)
Overview Assessment of Needs This webinar will discuss current data around antiretroviral management of HIV, including new data presented at the 31st Conference on Retroviruses and Opportunistic Infections. Learning Objectives On completion of this activity, learners will be able to: List the most recent findings from clinical studies in antiretroviral management of HIV and (more…)
The ART of HIV and STI Prevention: Update From the 2024 Conference on Retroviruses and Opportunistic Infections (CROI)
Overview Assessment of Needs This webinar discusses current and new data around prevention of HIV and prevention of sexually transmitted infections, including new data presented at the 31st Conference on Retroviruses and Opportunistic Infections (CROI). Learning Objectives On completion of this activity, learners will be able to: Describe the current approaches for HIV prevention (more…)
Implementation Science From an HIV Clinician’s Perspective
Overview Assessment of Needs Implementation science is an innovative approach to clinical research that identifies and addresses obstacles and facilitators to the uptake of evidence-based clinical innovations. This webinar addresses how implementation science has been utilized to address inequities in access to care, particularly for the clinical use of preexposure prophylaxis (PrEP) to prevent (more…)
HIV Cure: Where Are We and Do We Have a Map?
Overview Assessment of Needs This webinar examines the persistent need for a cure for HIV despite effective and continuously improving antiretroviral therapies. This webinar describes strategies that are being explored toward an HIV cure and explain why combinations of these or other potential approaches may be necessary. Current data, limitations, and future directions (more…)
Prevention and Treatment of Opportunistic Infections in People With HIV
Overview Assessment of Needs People with HIV-associated immunosuppression and people with HIV who are not on antiretroviral therapy can be at increased risk of opportunistic infections caused by viruses, bacteria, fungi, and protozoa. This webinar provides an update on what clinicians need to know regarding the prevention and treatment of common opportunistic infections in (more…)